- Home
- REXR vs ROIV Comparison
REXR vs ROIV Comparison
Compare REXR & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- ROIV
- Stock Information
- Founded
- REXR 2013
- ROIV 2014
- Country
- REXR United States
- ROIV United Kingdom
- Employees
- REXR N/A
- ROIV N/A
- Industry
- REXR Real Estate Investment Trusts
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- REXR Real Estate
- ROIV Health Care
- Exchange
- REXR Nasdaq
- ROIV Nasdaq
- Market Cap
- REXR 9.6B
- ROIV 8.4B
- IPO Year
- REXR 2013
- ROIV N/A
- Fundamental
- Price
- REXR $42.01
- ROIV $11.20
- Analyst Decision
- REXR Hold
- ROIV Strong Buy
- Analyst Count
- REXR 9
- ROIV 9
- Target Price
- REXR $50.89
- ROIV $17.69
- AVG Volume (30 Days)
- REXR 2.0M
- ROIV 4.3M
- Earning Date
- REXR 10-16-2024
- ROIV 11-12-2024
- Dividend Yield
- REXR 3.98%
- ROIV N/A
- EPS Growth
- REXR 17.01
- ROIV N/A
- EPS
- REXR 1.23
- ROIV 5.89
- Revenue
- REXR $903,937,000.00
- ROIV $129,128,999.00
- Revenue This Year
- REXR N/A
- ROIV $48.37
- Revenue Next Year
- REXR $12.78
- ROIV $13.76
- P/E Ratio
- REXR $34.15
- ROIV $1.99
- Revenue Growth
- REXR 18.01
- ROIV 145.68
- 52 Week Low
- REXR $41.16
- ROIV $8.56
- 52 Week High
- REXR $58.02
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- REXR 36.61
- ROIV 39.17
- Support Level
- REXR $41.16
- ROIV $11.53
- Resistance Level
- REXR $43.54
- ROIV $12.05
- Average True Range (ATR)
- REXR 0.99
- ROIV 0.32
- MACD
- REXR 0.04
- ROIV -0.03
- Stochastic Oscillator
- REXR 23.88
- ROIV 6.12
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in the acquisition, ownership, and operation of industrial properties in Southern California. The company mainly focuses on leasing facilities in infill markets or relatively wealthy urban areas with a general scarcity of developable land. The vast majority of Rexford's real estate portfolio, in terms of square footage, revenue generation, and total value, comprises light manufacturing and distribution warehouse buildings located in Los Angeles and San Diego. The company's tenants are firms in the wholesale and retail, light manufacturing, industrial equipment, and food and beverage industries.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.